Full-Time

Senior Director FP&a

Commercial & Business Development

Posted on 10/16/2024

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$215k - $268.6kAnnually

+ Bonus + Equity Awards

Senior

San Diego, CA, USA

Hybrid model requires in-office presence three days per week.

Category
Business Development
Business & Strategy
Required Skills
NetSuite
Financial analysis
Requirements
  • Bachelor’s degree in Accounting or Finance with CPA/CFA/MBA preferred.
  • 12 plus years of experience in corporate finance, banking, or consulting with pharma experience in a commercial stage organization required.
  • High level of intellectual curiosity, with ability to work independently and solve complex problems.
  • Experience with Commercial operations and business development valuation in the pharma industry.
  • Financial analysis skills and ability to translate analyses into sound strategic recommendations.
  • Ability to think strategically and communicate effectively across all levels of the organization.
  • Proven track record of reliable, detailed and accurate work product.
  • Ability to work in a results-oriented, project-driven, real-time team environment, prioritize projects and deliver quality results within tight time constraints.
  • Excellent written and verbal communication, presentation skills, and MS Office proficiency.
  • Working knowledge of Generally Accepted Accounting Principles (US GAAP).
  • Experience with NetSuite and Workday Adaptive Planning a plus.
Responsibilities
  • Act as integrated business partner with Commercial and Medical Affairs organizations, providing thought leadership and analysis for business initiatives (go/no go decisions, resource allocation, scenario analysis, payback periods, project post mortems, etc.) for both US and international businesses.
  • Develop gross-to-net forecast for all product lines, with extensive understanding of payer mix, discount structures by entity, and regulatory changes.
  • Lead and manage revenue and SG&A expense forecasts for all recurring planning processes (forecasts, annual operating plan, long range plan, etc.).
  • Develop, implement, and maintain expense reporting and variance analysis to functional business partners and finance leadership, driving continuous improvement in forecasting and reporting.
  • Serve as finance partner to the Business Development deal team. Responsible for maintaining and improving corporate valuation model, acting as finance representative in diligence team meetings, performing extensive financial analysis, and providing strategic input throughout the entire diligence process.
  • Hire, develop, and retain high performing team.
  • Support sourcing team to proactively highlight vendor risks/opportunities and partake in vendor selection process and governance meetings.
  • Collaborate with Accounting to ensure GAAP compliance and adherence to company policies and procedures as well as reasonableness of accruals.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
  • Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
  • The rise of personalized medicine aligns with Acadia's targeted therapy approach.

What critics are saying

  • Increased competition in CNS drug market may impact Acadia's market share.
  • Potential clinical trial delays could affect drug approval timelines.
  • Dependence on partnerships poses risks if collaborations face challenges or dissolve.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
  • The company has a strong R&D foundation, developing innovative small molecule drugs.
  • Acadia's strategic partnerships enhance its research capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

INACTIVE